Inventiva Sa (IVA) Stock Analysis

Inventiva Sa (IVA) is a publicly traded company in the HEALTHCARE sector. It trades at $4.09, carries a market capitalization of $996.68M. This page summarizes the public market data, fundamentals, and frequently asked questions for IVA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Inventiva Sa currently has a Bullish sentiment score of 0.17.

About Inventiva Sa

Inventiva SA (IVA) is a clinical-stage biopharmaceutical firm based in Daix, France, focused on pioneering oral small molecule therapies for high unmet medical conditions, notably non-alcoholic steatohepatitis (NASH) and mucopolysaccharidosis (MPS). With a strong pipeline of proprietary drug candidates, the company is dedicated to tackling complex metabolic and rare diseases, positioning itself as a significant contributor to advancements in the biopharmaceutical industry. As it progresses to...

GNG Research Analysis

GNG Research scores Inventiva Sa (IVA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for IVA.

Frequently Asked Questions

Does IVA pay dividends?

Inventiva Sa (IVA) does not currently pay a regular dividend.

What is IVA's market cap?

Inventiva Sa (IVA) has a market capitalization of $996.68M with a current stock price of $4.09.